MY190433A - Heterocyclic compounds and uses thereof - Google Patents

Heterocyclic compounds and uses thereof

Info

Publication number
MY190433A
MY190433A MYPI2017000112A MYPI2017000112A MY190433A MY 190433 A MY190433 A MY 190433A MY PI2017000112 A MYPI2017000112 A MY PI2017000112A MY PI2017000112 A MYPI2017000112 A MY PI2017000112A MY 190433 A MY190433 A MY 190433A
Authority
MY
Malaysia
Prior art keywords
egfr
pyrimidine
disclosed
pharmaceutical compositions
compositions containing
Prior art date
Application number
MYPI2017000112A
Inventor
Juswinder Singh
Kwangho Lee
Deqiang Niu
Russell C Petter
Matthew Frank Baevsky
Original Assignee
Celgene Car Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Car Llc filed Critical Celgene Car Llc
Publication of MY190433A publication Critical patent/MY190433A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Heterocyclic pyrimidine compounds that modulate mutant-selective epidermal growth factor receptor (EGFR) kinase activity are disclosed. Selectivity in inhibition of various mutant-EGFR is disclosed. Pharmaceutical compositions containing the pyrimidine derivatives, and methods of treating diseases associated with EGFR kinase activity comprising administration of the pyrimidine derivatives or pharmaceutical compositions containing the pyrimidine derivative, are described. [No suitable figure]
MYPI2017000112A 2010-11-01 2011-10-31 Heterocyclic compounds and uses thereof MY190433A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40908010P 2010-11-01 2010-11-01
US41182910P 2010-11-09 2010-11-09
US41233010P 2010-11-10 2010-11-10

Publications (1)

Publication Number Publication Date
MY190433A true MY190433A (en) 2022-04-21

Family

ID=56761369

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017000112A MY190433A (en) 2010-11-01 2011-10-31 Heterocyclic compounds and uses thereof

Country Status (2)

Country Link
AU (1) AU2016210613B2 (en)
MY (1) MY190433A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX357627B (en) * 2008-06-27 2018-07-17 Avila Therapeutics Inc Heteroaryl compounds and uses thereof.

Also Published As

Publication number Publication date
AU2016210613A1 (en) 2016-08-18
AU2016210613B2 (en) 2018-03-01

Similar Documents

Publication Publication Date Title
PH12015501483A1 (en) Heterocyclic compounds and uses thereof
PH12015501965A1 (en) Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
PH12014501504A1 (en) THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES
AU2012284088A8 (en) Heterocyclic compounds and uses thereof
WO2012064973A3 (en) Heterocyclic compounds and uses thereof
WO2014011900A3 (en) Inhibitors of the fibroblast growth factor receptor
SG10201902074UA (en) Heterocyclic compounds and uses thereof
MX342873B (en) Substituted pyrazolo-quinazoline derivatives as kinase inhibitors.
PH12012502438A1 (en) Morpholino pyrimidines and their use in therapy
SG11201408052WA (en) IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS
MY174196A (en) Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
WO2010099379A8 (en) Jak kinase modulating quinazoline derivatives and methods of use thereof
MY175979A (en) Certain chemical entities, compositions and methods
WO2010005876A3 (en) Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
WO2009007749A3 (en) Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
NZ630721A (en) Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
WO2012017239A3 (en) 4-(1h-indol-3-yl) -pyrimidines as alk inhibitors
MY162604A (en) Heterocyclic compounds and uses thereof
WO2011093672A3 (en) Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase
PH12013501594A1 (en) Substituted indazole derivatives active as kinase inhibitors
WO2009007748A3 (en) Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
MX2009011950A (en) Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors.
WO2011014795A3 (en) Compounds and compositions as syk kinase inhibitors
WO2014033447A3 (en) Diaryl urea derivatives as p38 map kinase inhibitors
MY167575A (en) Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases